References
- Bolton C. H., Hampton J. R., Mitchell J. R.A. Effect of oral contraceptive agents on platelets and plasmaphospholipids. Lancet 1968; 1: 1336
- Drill V. A., Calhoun D. W. Oral contraceptives and thromboembolic disease. JAMA 1968; 206: 77
- Editorials. Oestrogens in the pill. Lancet 1970; 1: 929
- Huggins C., Clark P. J. Quantitative studies of the prostatic secretion. II. The effect of castration and estrogen injection on the normal and the hyperplastic prostate glands of dogs. J Exp Med 1940; 72: 747
- Inman W. H. W., Vessey M. P. Investigation of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of childbearing age. Brit Med J 1968; II: 19
- Jönsson G. Om hormoner och hormonterapi, Borell. Wezäta, Göteborg 1964; 174
- Kontturi M., Sotaniemi E. Effect of estrogen on liver function of prostatic cancer patients. Brit Med J 1969; IV: 204
- Kontturi M., Sotaniemi E. Effect of estrogen on the serum cholesterol and triglyceride levels of prostatic cancer patients. J Urol. 1970, In press
- Kontturi M., Sotaniemi E. Estrogen induced metabolic changes during treatment of prostatic cancer. Scand J Clin Lab Invest 1970; 25: 45, suppl. 113
- Oliver M. F., Boyd G. S. Influence of reduction of serum lipids on prognosis of coronary heart disease. A five-year study using estrogens. Lancet 1961; II: 499
- Sartwell P. E., Masi A.T, Arthes F. G., Greene G. R., Smith H. E. Thromboembolism and oral contraceptives: Results of an epidemiological study of 175 cases and matched controls. J Lab dim Med 1969; 74: 1005
- The Veterans Administration Co-operative Urological Research Group 1967. Treatment and survival of patients with cancer of prostate. Surg Gynec Obstet, 124: 1011
- Vessey M. P. Oral contraceptives and thrombolic disease. Amer Heart J 1969; 77: 153
- Wynn V., Doar J. W. H., Mills G. L., Stokes T. Fasting serum triglyceride, cholesterol and lipoprotein levels during oral contraceptive therapy. Lancet 1969; II: 756